Jason Throne Ideaya Biosciences, Inc. (IDYA) insider trading activity

Jason Throne is Chief Legal Officer of IDEAYA Biosciences, Inc.. Currently has a direct ownership of 63,484 shares of IDYA, which is worth approximately $1.58 Million. The most recent transaction as insider was on Jun 27, 2024, when has been sold 53,484 shares (Common Stock) at a price of $10.18 per share, resulting in proceeds of $544,467. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.5K

0% 3M change

534.84% 12M change

Total Value Held $1.58 Million

Jason Throne Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 27 2024	BUY Exercise of conversion of derivative security	$544,467 $10.18 p/Share	53,484 Added 45.73%	63,484 Common Stock
Dec 18 2023	BUY Exercise of conversion of derivative security	$70,100 $7.01 p/Share	10,000 Added 50.0%	10,000 Common Stock
Dec 15 2023	SELL Open market or private sale	$350,400 $35.04 p/Share	10,000 Reduced 100.0%	0 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$133,400 $13.34 p/Share	10,000 Added 50.0%	10,000 Common Stock
Nov 03 2023	SELL Open market or private sale	$155,354 $30.09 p/Share	5,163 Reduced 100.0%	0 Common Stock
Nov 03 2023	BUY Exercise of conversion of derivative security	$66,396 $12.86 p/Share	5,163 Added 50.0%	5,163 Common Stock
Sep 12 2023	SELL Open market or private sale	$30,010 $30.01 p/Share	1,000 Reduced 100.0%	0 Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$12,860 $12.86 p/Share	1,000 Added 50.0%	1,000 Common Stock
Sep 05 2023	SELL Open market or private sale	$52,162 $30.03 p/Share	1,737 Reduced 100.0%	0 Common Stock
Sep 05 2023	BUY Exercise of conversion of derivative security	$22,337 $12.86 p/Share	1,737 Added 50.0%	1,737 Common Stock
Sep 01 2023	SELL Open market or private sale	$63,063 $30.03 p/Share	2,100 Reduced 100.0%	0 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$27,006 $12.86 p/Share	2,100 Added 50.0%	2,100 Common Stock
Aug 09 2023	SELL Open market or private sale	$125,450 $25.09 p/Share	5,000 Reduced 100.0%	0 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$66,700 $13.34 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jul 10 2023	SELL Open market or private sale	$218,155 $23.0 p/Share	9,485 Reduced 100.0%	0 Common Stock
Jul 10 2023	BUY Exercise of conversion of derivative security	$94,280 $9.94 p/Share	9,485 Added 50.0%	9,485 Common Stock
Jun 01 2023	SELL Open market or private sale	$81,790 $23.02 p/Share	3,553 Reduced 100.0%	0 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	$24,906 $7.01 p/Share	3,553 Added 50.0%	3,553 Common Stock
May 31 2023	SELL Open market or private sale	$9,936 $23.0 p/Share	432 Reduced 100.0%	0 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	$3,028 $7.01 p/Share	432 Added 50.0%	432 Common Stock
May 22 2023	SELL Open market or private sale	$11,500 $23.0 p/Share	500 Reduced 100.0%	0 Common Stock
May 22 2023	BUY Exercise of conversion of derivative security	$3,505 $7.01 p/Share	500 Added 50.0%	500 Common Stock
Jul 27 2021	SELL Open market or private sale	$251,700 $25.17 p/Share	10,000 Reduced 100.0%	0 Common Stock
Jul 27 2021	BUY Exercise of conversion of derivative security	$133,400 $13.34 p/Share	10,000 Added 50.0%	10,000 Common Stock
Jul 06 2021	SELL Open market or private sale	$224,200 $22.42 p/Share	10,000 Reduced 100.0%	0 Common Stock

Jason Throne

Chief Legal Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDYA shares.

Notify only if

Value

Insider Trading

Get notified when an Ideaya Biosciences, Inc. insider buys or sells IDYA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IDEAYA Biosciences, Inc.

Track Activities on IDYA

Account